Steffen Pietzke - Jul 14, 2021 Form 4 Insider Report for Enovix Corp (ENVX)

Role
Chief Financial Officer
Signature
/s/ Edward J. Hejlek, Attorney-in-Fact for Steffen Pietzke
Stock symbol
ENVX
Transactions as of
Jul 14, 2021
Transactions value $
$0
Form type
4
Date filed
7/16/2021, 08:56 PM
Next filing
Aug 12, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENVX Stock Option (Right to Buy) Award +277K 277K Jul 14, 2021 Common Stock 277K $9.26 Direct F1, F2, F3
transaction ENVX Stock Option (Right to Buy) Award +71K 71K Jul 14, 2021 Common Stock 71K $9.26 Direct F1, F4, F5
transaction ENVX Stock Option (Right to Buy) Award +369K 369K Jul 14, 2021 Common Stock 369K $9.26 Direct F1, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received pursuant to the Agreement and Plan of Merger, dated as of February 22, 2021, by and among Rodgers Silicon Valley Acquisition Corp, a Delaware corporation ("RSVAC"), RSVAC Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of RSVAC ("Merger Sub"), and Enovix Corporation, a Delaware corporation ("Legacy Enovix"), pursuant to which (i) Merger Sub merged with and into Enovix, with Enovix surviving the merger as a wholly owned subsidiary of RSVAC and (ii) RSVAC changed its name to Enovix Corporation.
F2 The shares subject to the option are immediately exercisable. 1/5th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 18, 2021, and 1/60th of the shares subject to the option will vest in 48 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
F3 Received in exchange for a stock option to purchase 1,500,000 shares of Legacy Enovix Common Stock.
F4 The shares subject to the option are immediately exercisable. 1/120th of the shares subject to the option vest monthly over 4 years beginning on the vesting commencement date, April 18, 2021, and 1/20th of the shares subject to the option vest monthly thereafter over the next year, subject to Reporting Person's continuous service through each such vesting date.
F5 Received in exchange for a stock option to purchase 384,700 shares of Legacy Enovix Common Stock.
F6 The shares subject to the option are immediately exercisable. 1/4th of the shares subject to the option vest on the one year anniversary of the vesting commencement date, April 1, 2021, and 1/48th of the shares subject to the option will vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
F7 Received in exchange for a stock option to purchase 2,000,000 shares of Legacy Enovix Common Stock.